δ-Catenin peptide vaccines repress hepatocellular carcinoma growth via CD8(+) T cell activation

As classical therapy method of advanced hepatocellular carcinoma (HCC) is not effective enough, HCC immunotherapy is a hot spot for research in recent years. Although in recent years, immune checkpoint inhibitors are focused in cancer therapy, vaccines and adoptive cell therapy (ACT), as traditional...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Oncoimmunology
Autori principali: Huang, Fei, Chen, Junying, Lan, Ruilong, Wang, Zeng, Chen, Ruiqing, Lin, Jingan, Zhang, Lurong, Fu, Lengxi
Natura: Artigo
Lingua:Inglês
Pubblicazione: Taylor & Francis 2018
Soggetti:
Original Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6136873/
https://ncbi.nlm.nih.gov/pubmed/30221043
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2018.1450713
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi